Skip to content

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00733200
Enrollment
Unknown
Registered
2008-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2009-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma, Hepatectomy, Surgical Treatment

Keywords

Minor Liver Resection, Major Liver Resection, Hilar

Brief summary

The investigators conducted a prospective study to determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in 138 patients with hilar cholangiocarcinoma. In selected patients, minor liver resection was a good treatment.

Detailed description

Objective: To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC). Summary Background Data: For HC treated with hepatectomy, the extent of liver resection remains controversial despite extensive studies. Methods: From January 2000 to December 2007, we prospectively studied patients who received surgical treatment for HC. Of the 187 patients who were surgically treated, 138 (73.8%) underwent resection with a curative intent. Minor hepatectomy was carried out in 93 patients who had Bismuth-Corlette types I, II and III HC without hepatic artery/portal vein invasion; and major hepatectomy in 45 patients who had type III HC with hepatic artery/portal vein invasion, or type IV HC.

Interventions

PROCEDUREMinor or Major Liver Resection

Sponsors

Ministry of Health, China
CollaboratorOTHER_GOV
Hepatic Surgery Clinical Research Centre of Hubei, China
CollaboratorUNKNOWN
Huazhong University of Science and Technology
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
26 Years to 72 Years
Healthy volunteers
No

Inclusion criteria

* Criteria for resectability were absence of peritoneal or liver metastases, tumor extension to beyond secondary biliary branches bilaterally, tumor extension to secondary portal venous branches bilaterally

Exclusion criteria

* not in accordance with the above criteria

Design outcomes

Primary

MeasureTime frame
On multivariate analysis, prognostic factors significantly impacted on long-term survival were UICC tumor stage and histopathologic grade.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026